Bioengineering extracellular vesicles as novel nanocarriers towards brain disorders

Feigin, V. L.; Vos, T.; Nichols, E.; Owolabi, M. O.; Carroll, W. M.; Dichgans, M.; Deuschl, G.; Parmar, P.; Brainin, M.; Murray, C. The global burden of neurological disorders: Translating evidence into policy. Lancet Neurol. 2020, 19, 255–265.

Charabati, M.; Rabanel, J. M.; Ramassamy, C.; Prat, A. Overcoming the brain barriers: From immune cells to nanoparticles. Trends Pharmacol. Sci. 2020, 41, 42–54.

Cui, J. W.; Xu, Y. X.; Tu, H. Y.; Zhao, H. C.; Wang, H. L.; Di, L. Q.; Wang, R. N. Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas. Acta Pharm. Sin. B 2022, 12, 1100–1125.

Croese, T.; Castellani, G.; Schwartz, M. Immune cell compartmentalization for brain surveillance and protection. Nat. Immunol. 2021, 22, 1083–1092.

Wu, P. P.; Zhang, B.; Ocansey, D. K. W.; Xu, W. R.; Qian, H. Extracellular vesicles: A bright star of nanomedicine. Biomaterials 2021, 269, 120467.

Van Niel, G.; D’Angelo, G.; Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 2018, 19, 213–228.

Morad, G.; Carman, C. V.; Hagedorn, E. J.; Perlin, J. R.; Zon, L. I.; Mustafaoglu, N.; Park, T. E.; Ingber, D. E.; Daisy, C. C.; Moses, M. A. Tumor-derived extracellular vesicles breach the intact blood-brain barrier via transcytosis. ACS Nano 2019, 13, 13853–13865.

Qiao, L.; Hu, S. Q.; Huang, K.; Su, T.; Li, Z. H.; Vandergriff, A.; Cores, J.; Dinh, P. U.; Allen, T.; Shen, D. L. et al. Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs. Theranostics 2020, 10, 3474–3487.

Wang, S. A.; Li, F.; Ye, T.; Wang, J. H.; Lyu, C. L.; Qing, S.; Ding, Z. W.; Gao, X. Y.; Jia, R. R.; Yu, D. et al. Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment. Sci. Transl. Med. 2021, 13, eabb6981.

Cong, M. H.; Tan, S. Y.; Li, S. M.; Gao, L. N.; Huang, L. Q.; Zhang, H. G.; Qiao, H. Z. Technology insight: Plant-derived vesicles-how far from the clinical biotherapeutics and therapeutic drug carriers? Adv. Drug Deliv. Rev. 2022, 182, 114108.

Zhang, J. H.; Ji, C.; Zhang, H. B.; Shi, H.; Mao, F.; Qian, H.; Xu, W. R.; Wang, D. Q.; Pan, J. M.; Fang, X. J. et al. Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy. Sci. Adv. 2022, 8, eabj8207.

Ma, M. M.; Gao, N.; Sun, Y. H.; Du, X. B.; Ren, J. S.; Qu, X. G. Redox-activated near-infrared-responsive polyoxometalates used for photothermal treatment of Alzheimer’s disease. Adv. Healthc. Mater. 2018, 7, 1800320.

Zan, G. T.; Wu, Q. S. Biomimetic and bioinspired synthesis of nanomaterials/nanostructures. Adv. Mater. 2016, 28, 2099–2147.

Kalluri, R.; LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 2020, 367, eaau6977.

He, C. J.; Zheng, S.; Luo, Y.; Wang, B. Exosome theranostics: Biology and translational medicine. Theranostics 2018, 8, 237–255.

Mathieu, M.; Martin-Jaular, L.; Lavieu, G.; Théry, C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat. Cell Biol. 2019, 21, 9–17.

Herrmann, I. K.; Wood, M. J. A.; Fuhrmann, G. Extracellular vesicles as a next-generation drug delivery platform. Nat. Nanotechnol. 2021, 16, 748–759.

Dinkla, S.; Van Cranenbroek, B.; Van Der Heijden, W. A.; He, X. H.; Wallbrecher, R.; Dumitriu, I. E.; Van Der Ven, A. J.; Bosman, G. J. C. G. M.; Koenen, H. J. P. M.; Joosten, I. Platelet microparticles inhibit IL-17 production by regulatory T cells through P-selectin. Blood 2016, 127, 1976–1986.

Bodega, G.; Alique, M.; Puebla, L.; Carracedo, J.; Ramírez, R. M. Microvesicles: ROS scavengers and ROS producers. J. Extracell. Vesicles 2019, 8, 1626654.

Gudbergsson, J. M.; Jønsson, K.; Simonsen, J. B.; Johnsen, K. B. Systematic review of targeted extracellular vesicles for drug delivery—Considerations on methodological and biological heterogeneity. J. Control. Release 2019, 306, 108–120.

Atkin-Smith, G. K.; Poon, I. K. H. Disassembly of the dying: Mechanisms and functions. Trends Cell Biol. 2017, 27, 151–162.

Chen, C. C.; Liu, L. N.; Ma, F. X.; Wong, C. W.; Guo, X. E.; Chacko, J. V.; Farhoodi, H. P.; Zhang, S. X.; Zimak, J.; Ségaliny, A. et al. Elucidation of exosome migration across the blood-brain barrier model in vitro. Cell. Mol. Bioeng. 2016, 9, 509–529.

Wang, J.; Tang, W.; Yang, M.; Yin, Y.; Li, H.; Hu, F. F.; Tang, L.; Ma, X. Y.; Zhang, Y.; Wang, Y. Z. Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy. Biomaterials 2021, 273, 120784.

Cheng, H.; Fan, J. H.; Zhao, L. P.; Fan, G. L.; Zheng, R. R.; Qiu, X. Z.; Yu, X. Y.; Li, S. Y.; Zhang, X. Z. Chimeric peptide engineered exosomes for dual-stage light guided plasma membrane and nucleus targeted photodynamic therapy. Biomaterials 2019, 211, 14–24.

Saint-Pol, J.; Gosselet, F.; Duban-Deweer, S.; Pottiez, G.; Karamanos, Y. Targeting and crossing the blood-brain barrier with extracellular vesicles. Cells 2020, 9, 851.

Gao, X. F.; Zhang, Z. H.; Mashimo, T.; Shen, B.; Nyagilo, J.; Wang, H.; Wang, Y. H.; Liu, Z. D.; Mulgaonkar, A.; Hu, X. L. et al. Gliomas interact with non-glioma brain cells via extracellular vesicles. Cell Rep. 2020, 30, 2489–2500.E5.

Holm, M. M.; Kaiser, J.; Schwab, M. E. Extracellular vesicles: Multimodal envoys in neural maintenance and repair. Trends Neurosci. 2018, 41, 360–372.

Shi, M.; Liu, C. Q.; Cook, T. J.; Bullock, K. M.; Zhao, Y. C.; Ginghina, C.; Li, Y. F.; Aro, P.; Dator, R.; He, C. M. et al. Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease. Acta Neuropathol. 2014, 128, 639–650.

Gagliardi, D.; Bresolin, N.; Comi, G. P.; Corti, S. Extracellular vesicles and amyotrophic lateral sclerosis: From misfolded protein vehicles to promising clinical biomarkers. Cell. Mol. Life Sci. 2021, 78, 561–572.

Lapointe, S.; Perry, A.; Butowski, N. A. Primary brain tumours in adults. Lancet 2018, 392, 432–446.

Zhong, J.; Xia, B. Z.; Shan, S. B.; Zheng, A. P.; Zhang, S. W.; Chen, J. G.; Liang, X. J. High-quality milk exosomes as oral drug delivery system. Biomaterials 2021, 277, 121126.

Han, L.; Lam, E. W. F.; Sun, Y. Extracellular vesicles in the tumor microenvironment: Old stories, but new tales. Mol. Cancer 2019, 18, 59.

Yekula, A.; Minciacchi, V. R.; Morello, M.; Shao, H. L.; Park, Y.; Zhang, X.; Muralidharan, K.; Freeman, M. R.; Weissleder, R.; Lee, H. et al. Large and small extracellular vesicles released by glioma cells in vitro and in vivo. J. Extracell. Vesicles 2019, 9, 1689784.

Lang, F. M.; Hossain, A.; Gumin, J.; Momin, E. N.; Shimizu, Y.; Ledbetter, D.; Shahar, T.; Yamashita, S.; Kerrigan, B. P.; Fueyo, J. et al. Mesenchymal stem cells as natural biofactories for exosomes carrying MiR-124a in the treatment of gliomas. Neuro-Oncol. 2018, 20, 380–390.

Zhu, Q. W.; Ling, X. Z.; Yang, Y. L.; Zhang, J. T.; Li, Q.; Niu, X.; Hu, G. W.; Chen, B.; Li, H. Y.; Wang, Y. et al. Embryonic stem cells-derived exosomes endowed with targeting properties as chemotherapeutics delivery vehicles for glioblastoma therapy. Adv. Sci. 2019, 6, 1801899.

Pegtel, D. M.; Peferoen, L.; Amor, S. Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2014, 369, 20130516.

Wang, J.; Ma, P.; Kim, D. H.; Liu, B. F.; Demirci, U. Towards microfluidic-based exosome isolation and detection for tumor therapy. Nano Today 2021, 37, 101066.

Zhang, Y.; Bi, J. Y.; Huang, J. Y.; Tang, Y. N.; Du, S. Y.; Li, P. Y. Exosome: A review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int. J. Nanomedicine 2020, 15, 6917–6934.

Yang, D. B.; Zhang, W. H.; Zhang, H. Y.; Zhang, F. Q.; Chen, L. M.; Ma, L. X.; Larcher, L. M.; Chen, S. X.; Liu, N.; Zhao, Q. X. et al. Progress, opportunity, and perspective on exosome isolation—Efforts for efficient exosome-based theranostics. Theranostics 2020, 10, 3684–3707.

Yáñez-Mó, M.; Siljander, P. R. M.; Andreu, Z.; Zavec, A. B.; Borràs, F. E.; Buzas, E. I.; Buzas, K.; Casal, E.; Cappello, F.; Carvalho, J. et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles 2015, 4, 27066.

Sisirak, V.; Sally, B.; D’Agati, V.; Martinez-Ortiz, W.; Özçakar, Z. B.; David, J.; Rashidfarrokhi, A.; Yeste, A.; Panea, C.; Chida, A. S. et al. Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity. Cell 2016, 166, 88–101.

Li, M. J.; Liao, L.; Tian, W. D. Extracellular vesicles derived from apoptotic cells: An essential link between death and regeneration. Front. Cell Dev. Biol. 2020, 8, 573511.

Jamjoom, A. A. B.; Rhodes, J.; Andrews, P. J. D.; Grant, S. G. N. The synapse in traumatic brain injury. Brain 2021, 144, 18–31.

Gill, J.; Mustapic, M.; Diaz-Arrastia, R.; Lange, R.; Gulyani, S.; Diehl, T.; Motamedi, V.; Osier, N.; Stern, R. A.; Kapogiannis, D. Higher exosomal tau, amyloid-beta 42 and IL-10 are associated with mild TBIs and chronic symptoms in military personnel. Brain Inj. 2018, 32, 1359–1366.

Manek, R.; Moghieb, A.; Yang, Z. H.; Kumar, D.; Kobessiy, F.; Sarkis, G. A.; Raghavan, V.; Wang, K. K. W. Protein biomarkers and neuroproteomics characterization of microvesicles/exosomes from human cerebrospinal fluid following traumatic brain injury. Mol. Neurobiol. 2018, 55, 6112–6128.

McBride, J. D.; Rodriguez-Menocal, L.; Guzman, W.; Candanedo, A.; Garcia-Contreras, M.; Badiavas, E. V. Bone marrow mesenchymal stem cell-derived CD63⁺ exosomes transport Wnt3a exteriorly and enhance dermal fibroblast proliferation, migration, and angiogenesis in vitro. Stem Cells Dev. 2017, 26, 1384–1398.

Upadhya, R.; Madhu, L. N.; Attaluri, S.; Gitaí, D. L. G.; Pinson, M. R.; Kodali, M.; Shetty, G.; Zanirati, G.; Kumar, S.; Shuai, B. et al. Extracellular vesicles from human IPSC-derived neural stem cells: MiRNA and protein signatures, and anti-inflammatory and neurogenic properties. J. Extracell. Vesicles 2020, 9, 1809064.

Pan, W.; Xu, X. H.; Zhang, M.; Song, X. Y. Human urine-derived stem cell-derived exosomal MiR-21-5p promotes neurogenesis to attenuate Rett syndrome via the EPha4/TEK axis. Lab. Invest. 2021, 101, 824–836.

Tian, T.; Cao, L.; He, C.; Ye, Q.; Liang, R. Y.; You, W. Y.; Zhang, H. X.; Wu, J. H.; Ye, J. H.; Tannous, B. A. et al. Targeted delivery of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia. Theranostics 2021, 11, 6507–6521.

Dugger, B. N.; Dickson, D. W. Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 2017, 9, a028035.

Reddy, P. H.; Oliver, D. M. A. Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer’s disease. Cells 2019, 8, 488.

Blauwendraat, C.; Heilbron, K.; Vallerga, C. L.; Bandres-Ciga, S.; Von Coelln, R.; Pihlstrøm, L.; Simón-Sánchez, J.; Schulte, C.; Sharma, M.; Krohn, L. et al. Parkinson’s disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms. Mov. Disord. 2019, 34, 866–875.

Van Es, M. A.; Hardiman, O.; Chio, A.; Al-Chalabi, A.; Pasterkamp, R. J.; Veldink, J. H.; Van Den Berg, L. H. Amyotrophic lateral sclerosis. Lancet 2017, 390, 2084–2098.

Sinha, M. S.; Ansell-Schultz, A.; Civitelli, L.; Hildesjö, C.; Larsson, M.; Lannfelt, L.; Ingelsson, M.; Hallbeck, M. Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. Acta Neuropathol. 2018, 136, 41–56.

Ruan, Z.; Pathak, D.; Kalavai, S. V.; Yoshii-Kitahara, A.; Muraoka, S.; Bhatt, N.; Takamatsu-Yukawa, K.; Hu, J. Q.; Wang, Y. Z.; Hersh, S. et al. Alzheimer’s disease brain-derived extracellular vesicles spread tau pathology in interneurons. Brain 2021, 144, 288–309.

Agosta, F.; Libera, D. D.; Spinelli, E. G.; Finardi, A.; Canu, E.; Bergami, A.; Chiavetto, L. B.; Baronio, M.; Comi, G.; Martino, G. et al. Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease. Ann. Neurol. 2014, 76, 813–825.

Stuendl, A.; Kunadt, M.; Kruse, N.; Bartels, C.; Moebius, W.; Danzer, K. M.; Mollenhauer, B.; Schneider, A. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies. Brain 2016, 139, 481–494.

Westergard, T.; Jensen, B. K.; Wen, X. M.; Cai, J. L.; Kropf, E.; Iacovitti, L.; Pasinelli, P.; Trotti, D. Cell-to-cell transmission of dipeptide repeat proteins linked to C9orf72-ALS/FTD. Cell Rep. 2016, 17, 645–652.

Gratpain, V.; Mwema, A.; Labrak, Y.; Muccioli, G. G.; Van Pesch, V.; Des Rieux, A. Extracellular vesicles for the treatment of central nervous system diseases. Adv. Drug Deliv. Rev. 2021, 174, 535–552.

Fiandaca, M. S.; Kapogiannis, D.; Mapstone, M.; Boxer, A.; Eitan, E.; Schwartz, J. B.; Abner, E. L.; Petersen, R. C.; Federoff, H. J.; Miller, B. L. et al. Identification of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimer’s Dement. 2015, 11, 600–607.E1.

Zhao, Z. H.; Chen, Z. T.; Zhou, R. L.; Zhang, X.; Ye, Q. Y.; Wang, Y. Z. Increased DJ-1 and α-synuclein in plasma neural-derived exosomes as potential markers for Parkinson’s disease. Front. Aging Neurosci. 2019, 10, 438.

Verderio, C.; Muzio, L.; Turola, E.; Bergami, A.; Novellino, L.; Ruffini, F.; Riganti, L.; Corradini, I.; Francolini, M.; Garzetti, L. et al. Myeloid microvesicles are a marker and therapeutic target for neuroinflammation. Ann. Neurol. 2012, 72, 610–624.

Minagar, A.; Jy, W.; Jimenez, J. J.; Sheremata, W. A.; Mauro, L. M.; Mao, W. W.; Horstman, L. L.; Ahn, Y. S. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 2001, 56, 1319–1324.

Yuyama, K.; Sun, H.; Usuki, S.; Sakai, S.; Hanamatsu, H.; Mioka, T.; Kimura, N.; Okada, M.; Tahara, H.; Furukawa, J. I. et al. A potential function for neuronal exosomes: Sequestering intracerebral amyloid-β peptide. FEBS Lett. 2015, 589, 84–88.

Trotta, T.; Panaro, M. A.; Cianciulli, A.; Mori, G.; Di Benedetto, A.; Porro, C. Microglia-derived extracellular vesicles in Alzheimer’s disease: A double-edged sword. Biochem. Pharmacol. 2018, 148, 184–192.

Calabria, E.; Scambi, I.; Bonafede, R.; Schiaffino, L.; Peroni, D.; Potrich, V.; Capelli, C.; Schena, F.; Mariotti, R. ASCs-exosomes recover coupling efficiency and mitochondrial membrane potential in an in vitro model of ALS. Front. Neurosci. 2019, 13, 1070.

Kim, J.; Inoue, K.; Ishii, J.; Vanti, W. B.; Voronov, S. V.; Murchison, E.; Hannon, G.; Abeliovich, A. A microRNA feedback circuit in midbrain dopamine neurons. Science 2007, 317, 1220–1224.

Zhang, Z. G.; Chopp, M. Exosomes in stroke pathogenesis and therapy. J. Clin. Invest. 2016, 126, 1190–1197.

Zhang, Z. G.; Buller, B.; Chopp, M. Exosomes—Beyond stem cells for restorative therapy in stroke and neurological injury. Nat. Rev. Neurol. 2019, 15, 193–203.

Witwer, K. W.; Van Balkom, B. W. M.; Bruno, S.; Choo, A.; Dominici, M.; Gimona, M.; Hill, A. F.; De Kleijn, D.; Koh, M.; Lai, R. C. et al. Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. J. Extracell. Vesicles 2019, 8, 1609206.

Perets, N.; Betzer, O.; Shapira, R.; Brenstein, S.; Angel, A.; Sadan, T.; Ashery, U.; Popovtzer, R.; Offen, D. Golden exosomes selectively target brain pathologies in neurodegenerative and neurodevelopmental disorders. Nano Lett. 2019, 19, 3422–3431.

Peng, H.; Li, Y.; Ji, W. H.; Zhao, R. C.; Lu, Z. G.; Shen, J.; Wu, Y. Y.; Wang, J. Z.; Hao, Q. L.; Wang, J. W. et al. Intranasal administration of self-oriented nanocarriers based on therapeutic exosomes for synergistic treatment of Parkinson’s disease. ACS Nano 2022, 16, 869–884.

Liu, C. P.; Wang, Y. C.; Li, L. M.; He, D. Y.; Chi, J. X.; Li, Q.; Wu, Y. X.; Zhao, Y. X.; Zhang, S. H.; Wang, L. et al. Engineered extracellular vesicles and their mimetics for cancer immunotherapy. J. Control. Release 2022, 349, 679–698.

Zhu, L. Y.; Oh, J. M.; Gangadaran, P.; Kalimuthu, S.; Baek, S. H.; Jeong, S. Y.; Lee, S. W.; Lee, J.; Ahn, B. C. Targeting and therapy of glioblastoma in a mouse model using exosomes derived from natural killer cells. Front. Immunol. 2018, 9, 824.

Xing, Y.; Sun, X.; Dou, Y. M.; Wang, M.; Zhao, Y. M.; Yang, Q.; Zhao, Y. H. The immuno-modulation effect of macrophage-derived extracellular vesicles in chronic inflammatory diseases. Front. Immunol. 2021, 12, 785728.

Huo, Q. H.; Shi, Y. J.; Qi, Y.; Huang, L. J.; Sui, H. J.; Zhao, L. Biomimetic silibinin-loaded macrophage-derived exosomes induce dual inhibition of Aβ aggregation and astrocyte activation to alleviate cognitive impairment in a model of Alzheimer’s disease. Mater. Sci. Eng. C 2021, 129, 112365.

Jiang, H. L.; Zhou, L.; Shen, N.; Ning, X. H.; Wu, D. Q.; Jiang, K. L.; Huang, X. S. M1 macrophage-derived exosomes and their key molecule LncRNA HOTTIP suppress head and neck squamous cell carcinoma progression by upregulating the TLR5/NF-ΚB pathway. Cell Death Dis. 2022, 13, 183.

Giese, M. A.; Hind, L. E.; Huttenlocher, A. Neutrophil plasticity in the tumor microenvironment. Blood 2019, 133, 2159–2167.

Grozdanov, V.; Bousset, L.; Hoffmeister, M.; Bliederhaeuser, C.; Meier, C.; Madiona, K.; Pieri, L.; Kiechle, M.; McLean, P. J.; Kassubek, J. et al. Increased immune activation by pathologic α-synuclein in Parkinson’s disease. Ann. Neurol. 2019, 86, 593–606.

Lindenbergh, M. F. S.; Wubbolts, R.; Borg, E. G. F.; Van ’T Veld, E. M.; Boes, M.; Stoorvogel, W. Dendritic cells release exosomes together with phagocytosed pathogen; potential implications for the role of exosomes in antigen presentation. J. Extracell. Vesicles 2020, 9, 1798606.

Liu, L. Y.; Li, Y.; Peng, H.; Liu, R. Y.; Ji, W. H.; Shi, Z. Y.; Shen, J.; Ma, G. H.; Zhang, X. Targeted exosome coating gene-chem nanocomplex as “nanoscavenger” for clearing α-synuclein and immune activation of Parkinson’s disease. Sci. Adv. 2020, 6, aba3967.

Qiu, Y. F.; Yang, Y.; Yang, R. Y.; Liu, C. X.; Hsu, J. M.; Jiang, Z.; Sun, L. L.; Wei, Y. K.; Li, C. W.; Yu, D. H. et al. Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer. Oncogene 2021, 40, 4992–5001.

Mashouri, L.; Yousefi, H.; Aref, A. R.; Ahadi, A. M.; Molaei, F.; Alahari, S. K. Exosomes: Composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol. Cancer 2019, 18, 75.

Yang, C.; Wu, Y.; Wang, L.; Li, S. D.; Zhou, J. H.; Tan, Y. L.; Song, J.; Xing, H. K.; Yi, K. K.; Zhan, Q. et al. Glioma-derived exosomes hijack the blood-brain barrier to facilitate nanocapsule delivery via LCN2. J. Control. Release 2022, 345, 537–548.

Dou, G.; Tian, R.; Liu, X. M.; Yuan, P. Y.; Ye, Q. W.; Liu, J.; Liu, S. Y.; Zhou, J.; Deng, Z. H.; Chen, X. et al. Chimeric apoptotic bodies functionalized with natural membrane and modular delivery system for inflammation modulation. Sci. Adv. 2020, 6, eaba2987.

Wang, Y. L.; Pang, J. Y.; Wang, Q. Y.; Yan, L. C.; Wang, L. T.; Xing, Z.; Wang, C. M.; Zhang, J. F.; Dong, L. Delivering antisense oligonucleotides across the blood-brain barrier by tumor cell-derived small apoptotic bodies. Adv. Sci. 2021, 8, 2004929.

Jang, Y.; Kim, H.; Yoon, S.; Lee, H.; Hwang, J.; Jung, J.; Chang, J. H.; Choi, J.; Kim, H. Exosome-based photoacoustic imaging guided photodynamic and immunotherapy for the treatment of pancreatic cancer. J. Control. Release 2021, 330, 293–304.

Zhou, X.; Miao, Y. Q.; Wang, Y.; He, S. F.; Guo, L. M.; Mao, J. S.; Chen, M. S.; Yang, Y. T.; Zhang, X. X.; Gan, Y. Tumour-derived extracellular vesicle membrane hybrid lipid nanovesicles enhance SiRNA delivery by tumour-homing and intracellular freeway transportation. J. Extracell. Vesicles 2022, 11, e12198.

Kim, D. K.; Rhee, W. J. Antioxidative effects of carrot-derived nanovesicles in cardiomyoblast and neuroblastoma cells. Pharmaceutics 2021, 13, 1203.

Logozzi, M.; Di Raimo, R.; Mizzoni, D.; Fais, S. Nanovesicles from organic agriculture-derived fruits and vegetables: Characterization and functional antioxidant content. Int. J. Mol. Sci. 2021, 22, 8170.

Zeng, L. P.; Wang, H. Y.; Shi, W. H.; Chen, L. F.; Chen, T. T.; Chen, G. Y.; Wang, W. S.; Lan, J. M.; Huang, Z. H.; Zhang, J. et al. Aloe derived nanovesicle as a functional carrier for indocyanine green encapsulation and phototherapy. J. Nanobiotechnol. 2021, 19, 439.

Zhao, J.; Zhao, Q.; Lu, J. Z.; Ye, D.; Mu, S.; Yang, X. D.; Zhang, W. D.; Ma, B. L. Natural nano-drug delivery system in Coptidis rhizoma extract with modified berberine hydrochloride pharmacokinetics. Int. J. Nanomedicine 2021, 16, 6297–6311.

Zhai, K. F.; Duan, H.; Wang, W.; Zhao, S. Y.; Khan, G. J.; Wang, M. T.; Zhang, Y. H.; Thakur, K.; Fang, X. M.; Wu, C. et al. Ginsenoside Rg1 ameliorates blood-brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes MiR-21 release. Acta Pharm. Sin. B 2021, 11, 3493–3507.

Xu, X. H.; Yuan, T. J.; Dad, H. A.; Shi, M. Y.; Huang, Y. Y.; Jiang, Z. H.; Peng, L. H. Plant exosomes as novel nanoplatforms for microRNA transfer stimulate neural differentiation of stem cells in vitro and in vivo. Nano Lett. 2021, 21, 8151–8159.

Han, X.; Wei, Q.; Lv, Y.; Weng, L.; Huang, H. Y.; Wei, Q. Y.; Li, M. Y.; Mao, Y. J.; Hua, D.; Cai, X. T. et al. Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment. Mol. Ther. 2022, 30, 327–340.

Long-Smith, C.; O’Riordan, K. J.; Clarke, G.; Stanton, C.; Dinan, T. G.; Cryan, J. F. Microbiota-gut-brain axis: New therapeutic opportunities. Annu. Rev. Pharmacol. Toxicol. 2020, 60, 477–502.

Guo, S. W.; Perets, N.; Betzer, O.; Ben-Shaul, S.; Sheinin, A.; Michaelevski, I.; Popovtzer, R.; Offen, D.; Levenberg, S. Intranasal delivery of mesenchymal stem cell derived exosomes loaded with phosphatase and tensin homolog SiRNA repairs complete spinal cord injury. ACS Nano 2019, 13, 10015–10028.

Dar, G. H.; Mendes, C. C.; Kuan, W. L.; Speciale, A. A.; Conceição, M.; Görgens, A.; Uliyakina, I.; Lobo, M. J.; Lim, W. F.; El Andaloussi, S. et al. GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated SiRNA delivery to the brain. Nat. Commun. 2021, 12, 6666.

Jahangard, Y.; Monfared, H.; Moradi, A.; Zare, M.; Mirnajafi-Zadeh, J.; Mowla, S. J. Therapeutic effects of transplanted exosomes containing MiR-29b to a rat model of Alzheimer’s disease. Front. Neurosci. 2020, 14, 564.

Haney, M. J.; Klyachko, N. L.; Zhao, Y. L.; Gupta, R.; Plotnikova, E. G.; He, Z. J.; Patel, T.; Piroyan, A.; Sokolsky, M.; Kabanov, A. V. et al. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J. Control. Release 2015, 207, 18–30.

Wang, H.; Sui, H. J.; Zheng, Y.; Jiang, Y. B.; Shi, Y. J.; Liang, J.; Zhao, L. Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the tau protein through the AKT/GSK-3β pathway. Nanoscale 2019, 11, 7481–7496.

Yuan, D. F.; Zhao, Y. L.; Banks, W. A.; Bullock, K. M.; Haney, M.; Batrakova, E.; Kabanov, A. V. Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain. Biomaterials 2017, 142, 1–12.

Wu, T. T.; Liu, Y.; Cao, Y.; Liu, Z. H. Engineering macrophage exosome disguised biodegradable nanoplatform for enhanced sonodynamic therapy of glioblastoma. Adv. Mater. 2022, 34, 2110364.

Izco, M.; Blesa, J.; Schleef, M.; Schmeer, M.; Porcari, R.; Al-Shawi, R.; Ellmerich, S.; De Toro, M.; Gardiner, C.; Seow, Y. et al. Systemic exosomal delivery of ShRNA minicircles prevents parkinsonian pathology. Mol. Ther. 2019, 27, 2111–2122.

Zhang, C.; Song, J.; Lou, L.; Qi, X. J.; Zhao, L.; Fan, B.; Sun, G. Z.; Lv, Z. Q.; Fan, Z. Z.; Jiao, B. H. et al. Doxorubicin-loaded nanoparticle coated with endothelial cells-derived exosomes for immunogenic chemotherapy of glioblastoma. Bioeng. Transl. Med. 2021, 6, e10203.

Tian, T.; Liang, R. Y.; Erel-Akbaba, G.; Saad, L.; Obeid, P. J.; Gao, J.; Chiocca, E. A.; Weissleder, R.; Tannous, B. A. Immune checkpoint inhibition in GBM primed with radiation by engineered extracellular vesicles. ACS Nano 2022, 16, 1940–1953.

Didiot, M. C.; Hall, L. M.; Coles, A. H.; Haraszti, R. A.; Godinho, B. M. D. C.; Chase, K.; Sapp, E.; Ly, S.; Alterman, J. F.; Hassler, M. R. et al. Exosome-mediated delivery of hydrophobically modified SiRNA for huntingtin MRNA silencing. Mol. Ther. 2016, 24, 1836–1847.

Qu, M. K.; Lin, Q.; Huang, L. Y.; Fu, Y.; Wang, L. Y.; He, S. S.; Fu, Y.; Yang, S. Y.; Zhang, Z. R.; Zhang, L. et al. Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson’s disease. J. Control. Release 2018, 287, 156–166.

Qi, Y.; Guo, L.; Jiang, Y. B.; Shi, Y. J.; Sui, H. J.; Zhao, L. Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles. Drug Deliv. 2020, 27, 745–755.

Kojima, R.; Bojar, D.; Rizzi, G.; Hamri, G. C. E.; El-Baba, M. D.; Saxena, P.; Ausländer, S.; Tan, K. R.; Fussenegger, M. Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment. Nat. Commun. 2018, 9, 1305.

Niu, W. B.; Xiao, Q.; Wang, X. J.; Zhu, J. Q.; Li, J. H.; Liang, X. M.; Peng, Y. M.; Wu, C. T.; Lu, R. J.; Pan, Y. et al. A biomimetic drug delivery system by integrating grapefruit extracellular vesicles and doxorubicin-loaded heparin-based nanoparticles for glioma therapy. Nano Lett. 2021, 21, 1484–1492.

You, J. Y.; Kang, S. J.; Rhee, W. J. Isolation of cabbage exosome-like nanovesicles and investigation of their biological activities in human cells. Bioact. Mater. 2021, 6, 4321–4332.

Lee, R.; Ko, H. J.; Kim, K.; Sohn, Y.; Min, S. Y.; Kim, J. A.; Na, D.; Yeon, J. H. Anti-melanogenic effects of extracellular vesicles derived from plant leaves and stems in mouse melanoma cells and human healthy skin. J. Extracell. Vesicles 2020, 9, 1703480.

Yang, M.; Liu, X. Y.; Luo, Q. Q.; Xu, L. L.; Chen, F. X. An efficient method to isolate lemon derived extracellular vesicles for gastric cancer therapy. J. Nanobiotechnol. 2020, 18, 100.

Yang, M.; Luo, Q. Q.; Chen, X.; Chen, F. X. Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma. J. Nanobiotechnol. 2021, 19, 259.

Chen, X. Y.; Zhou, Y.; Yu, J. J. Exosome-like nanoparticles from ginger rhizomes inhibited NLRP3 inflammasome activation. Mol. Pharmaceutics 2019, 16, 2690–2699.

Sundaram, K.; Miller, D. P.; Kumar, A.; Teng, Y.; Sayed, M.; Mu, J. Y.; Lei, C.; Sriwastva, M. K.; Zhang, L. F.; Yan, J. et al. Plant-derived exosomal nanoparticles inhibit pathogenicity of Porphyromonas gingivalis. iScience 2020, 23, 100869.

Liu, B. L.; Lu, Y. Z.; Chen, X. Y.; Muthuraj, P. G.; Li, X. Z.; Pattabiraman, M.; Zempleni, J.; Kachman, S. D.; Natarajan, S. K.; Yu, J. J. Protective role of shiitake mushroom-derived exosome-like nanoparticles in D-galactosamine and lipopolysaccharide-induced acute liver injury in mice. Nutrients 2020, 12, 477.

Liu, B. L.; Li, X. Z.; Yu, H.; Shi, X.; Zhou, Y.; Alvarez, S.; Naldrett, M. J.; Kachman, S. D.; Ro, S. H.; Sun, X. H. et al. Therapeutic potential of garlic chive-derived vesicle-like nanoparticles in NLRP3 inflammasome-mediated inflammatory diseases. Theranostics 2021, 11, 9311–9330.

Cao, M.; Yan, H. J.; Han, X.; Weng, L.; Wei, Q.; Sun, X. Y.; Lu, W. G.; Wei, Q. Y.; Ye, J.; Cai, X. T. et al. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth. J. Immunother. Cancer 2019, 7, 326.

Zhang, L.; He, F. J.; Gao, L. N.; Cong, M. H.; Sun, J.; Xu, J. L.; Wang, Y. T.; Hu, Y.; Asghar, S.; Hu, L. H. et al. Engineering exosome-like nanovesicles derived from Asparagus cochinchinensis can inhibit the proliferation of hepatocellular carcinoma cells with better safety profile. Int. J. Nanomedicine 2021, 16, 1575–1586.

Tong, L. J.; Hao, H. N.; Zhang, Z.; Lv, Y. Y.; Liang, X.; Liu, Q. Q.; Liu, T. J.; Gong, P. M.; Zhang, L. W.; Cao, F. F. et al. Milk-derived extracellular vesicles alleviate ulcerative colitis by regulating the gut immunity and reshaping the gut microbiota. Theranostics 2021, 11, 8570–8586.

Lei, J. H.; Jiang, X. Y.; Li, W.; Ren, J.; Wang, D. T.; Ji, Z. J.; Wu, Z. M.; Cheng, F.; Cai, Y. S.; Yu, Z. R. et al. Exosomes from antler stem cells alleviate mesenchymal stem cell senescence and osteoarthritis. Protein Cell 2022, 13, 220–226.

Chen, X. Y.; Liu, B. L.; Li, X. Z.; An, T. T.; Zhou, Y.; Li, G.; Wu-Smart, J.; Alvarez, S.; Naldrett, M. J.; Eudy, J. et al. Identification of anti-inflammatory vesicle-like nanoparticles in honey. J. Extracell. Vesicles 2021, 10, e12069.

Park, K. S.; Svennerholm, K.; Crescitelli, R.; Lässer, C.; Gribonika, I.; Lötvall, J. Synthetic bacterial vesicles combined with tumour extracellular vesicles as cancer immunotherapy. J. Extracell. Vesicles 2021, 10, e12120.

Haraszti, R. A.; Miller, R.; Didiot, M. C.; Biscans, A.; Alterman, J. F.; Hassler, M. R.; Roux, L.; Echeverria, D.; Sapp, E.; DiFiglia, M. et al. Optimized cholesterol-SiRNA chemistry improves productive loading onto extracellular vesicles. Mol. Ther. 2018, 26, 1973–1982.

Lunavat, T. R.; Jang, S. C.; Nilsson, L.; Park, H. T.; Repiska, G.; Lässer, C.; Nilsson, J. A.; Gho, Y. S.; Lötvall, J. RNAi delivery by exosome-mimetic nanovesicles—Implications for targeting c-Myc in cancer. Biomaterials 2016, 102, 231–238.

Cooper, J. M.; Wiklander, P. B. O.; Nordin, J. Z.; Al-Shawi, R.; Wood, M. J.; Vithlani, M.; Schapira, A. H. V.; Simons, J. P.; El-Andaloussi, S.; Alvarez-Erviti, L. Systemic exosomal SiRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov. Disord. 2014, 29, 1476–1485.

Wang, K.; Kumar, U. S.; Sadeghipour, N.; Massoud, T. F.; Paulmurugan, R. A microfluidics-based scalable approach to generate extracellular vesicles with enhanced therapeutic MicroRNA loading for intranasal delivery to mouse glioblastomas. ACS Nano 2021, 15, 18327–18346.

Yang, Z. G.; Shi, J. F.; Xie, J.; Wang, Y. F.; Sun, J. Y.; Liu, T. Z.; Zhao, Y. R.; Zhao, X. T.; Wang, X. M.; Ma, Y. F. et al. Large-scale generation of functional MRNA-encapsulating exosomes via cellular nanoporation. Nat. Biomed. Eng. 2020, 4, 69–83.

Lai, C. P.; Mardini, O.; Ericsson, M.; Prabhakar, S.; Maguire, C. A.; Chen, J. W.; Tannous, B. A.; Breakefield, X. O. Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano 2014, 8, 483–494.

Liu, Y.; Huang, R. Q.; Han, L.; Ke, W. L.; Shao, K.; Ye, L. Y.; Lou, J. N.; Jiang, C. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Biomaterials 2009, 30, 4195–4202.

Alvarez-Erviti, L.; Seow, Y.; Yin, H. F.; Betts, C.; Lakhal, S.; Wood, M. J. A. Delivery of SiRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 2011, 29, 341–345.

Yu, X. Y.; Bai, Y.; Han, B.; Ju, M. Z.; Tang, T. C.; Shen, L.; Li, M. Y.; Yang, L.; Zhang, Z.; Hu, G. K. et al. Extracellular vesicle-mediated delivery of CircDYM alleviates CUS-induced depressive-like behaviours. J. Extracell. Vesicles 2022, 11, e12185.

Kim, G.; Kim, M.; Lee, Y.; Byun, J. W.; Hwang, D. W.; Lee, M. Systemic delivery of MicroRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes. J. Control. Release 2020, 317, 273–281.

Huang, R. X.; Rofstad, E. K. Integrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma. J. Exp. Clin. Cancer Res. 2018, 37, 92.

Mead, B. P.; Mastorakos, P.; Suk, J. S.; Klibanov, A. L.; Hanes, J.; Price, R. J. Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound. J. Control. Release 2016, 223, 109–117.

Du, J. B.; Wan, Z.; Wang, C.; Lu, F.; Wei, M. Y.; Wang, D. S.; Hao, Q. Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy. Theranostics 2021, 11, 8185–8196.

Kamerkar, S.; LeBleu, V. S.; Sugimoto, H.; Yang, S. J.; Ruivo, C. F.; Melo, S. A.; Lee, J. J.; Kalluri, R. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 2017, 546, 498–503.

Chen, Y. D.; Wang, L. X.; Zheng, M. F.; Zhu, C. D.; Wang, G. S.; Xia, Y. Q.; Blumenthal, E. J.; Mao, W. J.; Wan, Y. Engineered extracellular vesicles for concurrent anti-PDL1 immunotherapy and chemotherapy. Bioact. Mater. 2022, 9, 251–265.

Li, L.; Yang, W. W.; Xu, D. G. Stimuli-responsive nanoscale drug delivery systems for cancer therapy. J. Drug Target. 2019, 27, 423–433.

Chen, M. C.; Lin, Z. W.; Ling, M. H. Near-infrared light-activatable microneedle system for treating superficial tumors by combination of chemotherapy and photothermal therapy. ACS Nano 2016, 10, 93–101.

Donohoe, C.; Senge, M. O.; Arnaut, L. G.; Gomes-Da-Silva, L. C. Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunity. Biochim. Biophys. Acta Rev. Cancer 2019, 1872, 188308.

Chang, M. Y.; Hou, Z. Y.; Wang, M.; Li, C. X.; Lin, J. Recent advances in hyperthermia therapy-based synergistic immunotherapy. Adv. Mater. 2021, 33, 2004788.

Chen, Q.; Xu, L. G.; Liang, C.; Wang, C.; Peng, R.; Liu, Z. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy. Nat. Commun. 2016, 7, 13193.

Zhang, W.; Yu, Z. L.; Wu, M.; Ren, J. G.; Xia, H. F.; Sa, G. L.; Zhu, J. Y.; Pang, D. W.; Zhao, Y. F.; Chen, G. Magnetic and folate functionalization enables rapid isolation and enhanced tumor-targeting of cell-derived microvesicles. ACS Nano 2017, 11, 277–290.

Wang, J.; Chen, P.; Dong, Y.; Xie, H.; Wang, Y. C.; Soto, F.; Ma, P.; Feng, X. J.; Du, W.; Liu, B. F. Designer exosomes enabling tumor targeted efficient chemo/gene/photothermal therapy. Biomaterials 2021, 276, 121056.

Bai, L. M.; Liu, Y. C.; Guo, K. L.; Zhang, K.; Liu, Q. H.; Wang, P.; Wang, X. B. Ultrasound facilitates naturally equipped exosomes derived from macrophages and blood serum for orthotopic glioma treatment. ACS Appl. Mater. Interfaces 2019, 11, 14576–14587.

Ji, W. H.; Li, Y.; Peng, H.; Zhao, R. C.; Zhang, X. Nature-inspired dynamic gene-loaded nanoassemblies for the treatment of brain diseases. Adv. Drug Deliv. Rev. 2022, 180, 114029.

Keith, B.; Simon, M. C. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007, 129, 465–472.

Filipczak, N.; Joshi, U.; Attia, S. A.; Fridman, I. B.; Cohen, S.; Konry, T.; Torchilin, V. Hypoxia-sensitive drug delivery to tumors. J. Control. Release 2022, 341, 431–442.

Wang, X. J.; Ding, H.; Li, Z. Y.; Peng, Y. N.; Tan, H.; Wang, C. L.; Huang, G. D.; Li, W. P.; Ma, G. H.; Wei, W. Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects. Signal Transduct. Target. Ther. 2022, 7, 74.

Niu, B. Y.; Liao, K. X.; Zhou, Y. X.; Wen, T.; Quan, G. L.; Pan, X.; Wu, C. B. Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy. Biomaterials 2021, 277, 121110.

Xiao, T. T.; He, M. J.; Xu, F.; Fan, Y.; Jia, B. Y.; Shen, M. W.; Wang, H.; Shi, X. Y. Macrophage membrane-camouflaged responsive polymer nanogels enable magnetic resonance imaging-guided chemotherapy/chemodynamic therapy of orthotopic glioma. ACS Nano 2021, 15, 20377–20390.

Li, M.; Li, S. Y.; Zhou, H.; Tang, X. F.; Wu, Y.; Jiang, W.; Tian, Z. G.; Zhou, X. C.; Yang, X. Z.; Wang, Y. C. Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy. Nat. Commun. 2020, 11, 1126.

D’Souza, A.; Dave, K. M.; Stetler, R. A.; Manickam, D. S. Targeting the blood-brain barrier for the delivery of stroke therapies. Adv. Drug Deliv. Rev. 2021, 171, 332–351.

Wang, Q.; Li, T.; Yang, J. Y.; Zhao, Z. N.; Tan, K. Y.; Tang, S. W.; Wan, M. M.; Mao, C. Engineered exosomes with independent module/cascading function for therapy of Parkinson’s disease by multistep targeting and multistage intervention method. Adv. Mater. 2022, 34, 2201406.

Li, Y. J.; Wu, J. Y.; Liu, J. H.; Xu, W. J.; Qiu, X. H.; Huang, S.; Hu, X. B.; Xiang, D. X. Artificial exosomes for translational nanomedicine. J. Nanobiotechnol. 2021, 19, 242.

Wu, J. Y.; Li, Y. J.; Hu, X. B.; Huang, S.; Luo, S. L.; Tang, T. T.; Xiang, D. X. Exosomes and biomimetic nanovesicles-mediated anti-glioblastoma therapy: A head-to-head comparison. J. Control. Release 2021, 336, 510–521.

Kim, H. Y.; Bhang, S. H. Stem cell-engineered nanovesicles exert proangiogenic and neuroprotective effects. Materials 2021, 14, 1078.

Lee, J. R.; Kyung, J. W.; Kumar, H.; Kwon, S. P.; Song, S. Y.; Han, I. B.; Kim, B. S. Targeted delivery of mesenchymal stem cell-derived nanovesicles for spinal cord injury treatment. Int. J. Mol. Sci. 2020, 21, 4185.

Yu, W. Y.; Yin, N.; Yang, Y.; Xuan, C. P.; Liu, X.; Liu, W.; Zhang, Z. Z.; Zhang, K. X.; Liu, J. J.; Shi, J. J. Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection. Acta Biomater. 2022, 140, 625–640.

Li, M. X.; Liu, Y.; Chen, J. P.; Liu, T. T.; Gu, Z. X.; Zhang, J. Q.; Gu, X. C.; Teng, G. J.; Yang, F.; Gu, N. Platelet bio-nanobubbles as microvascular recanalization nanoformulation for acute ischemic stroke lesion theranostics. Theranostics 2018, 8, 4870–4883.

Dong, X. Y.; Gao, J.; Zhang, C. Y.; Hayworth, C.; Frank, M.; Wang, Z. J. Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke. ACS Nano 2019, 13, 1272–1283.

Meng, L. T.; Wang, C. R.; Lu, Y. P.; Sheng, G.; Yang, L.; Wu, Z. Y.; Xu, H.; Han, C.; Lu, Y. M.; Han, F. Targeted regulation of blood-brain barrier for enhanced therapeutic efficiency of hypoxia-modifier nanoparticles and immune checkpoint blockade antibodies for glioblastoma. ACS Appl. Mater. Interfaces 2021, 13, 11657–11671.

Fernandes, M.; Lopes, I.; Magalhães, L.; Sárria, M. P.; Machado, R.; Sousa, J. C.; Botelho, C.; Teixeira, J.; Gomes, A. C. Novel concept of exosome-like liposomes for the treatment of Alzheimer’s disease. J. Control. Release 2021, 336, 130–143.

Wu, J. Y.; Li, Y. J.; Wang, J. M.; Hu, X. B.; Huang, S.; Luo, S. L.; Xiang, D. X. Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona. J. Nanobiotechnol. 2021, 19, 405.

Shende, P.; Trivedi, R. Biofluidic material-based carriers: Potential systems for crossing cellular barriers. J. Control. Release 2021, 329, 858–870.

Tian, X.; Fan, T. J.; Zhao, W. T.; Abbas, G.; Han, B.; Zhang, K.; Li, N.; Liu, N.; Liang, W. Y.; Huang, H. et al. Recent advances in the development of nanomedicines for the treatment of ischemic stroke. Bioact. Mater. 2021, 6, 2854–2869.

Wang, J.; Zhu, M. T.; Nie, G. J. Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles. Adv. Drug Deliv. Rev. 2021, 178, 113974.

Gregoriadis, G.; Ryman, B. E. Liposomes as carriers of enzymes or drugs: A new approach to the treatment of storage diseases. Biochem. J. 1971, 124, 58P.

Khan, A. R.; Yang, X. Y.; Fu, M. F.; Zhai, G. X. Recent progress of drug nanoformulations targeting to brain. J. Control. Release 2018, 291, 37–64.

Zheng, Z. N.; Zhang, J. X.; Jiang, J. Z.; He, Y.; Zhang, W. Y.; Mo, X. P.; Kang, X. J.; Xu, Q.; Wang, B.; Huang, Y. Z. Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery. J. Immunother. Cancer 2020, 8, e000207.

Skrott, Z.; Mistrik, M.; Andersen, K. K.; Friis, S.; Majera, D.; Gursky, J.; Ozdian, T.; Bartkova, J.; Turi, Z.; Moudry, P. et al. Alcohol-abuse drug disulfiram targets cancer via P97 segregase adaptor NPL4. Nature 2017, 552, 194–199.

Hou, J.; Yang, X.; Li, S. Y.; Cheng, Z. K.; Wang, Y. H.; Zhao, J.; Zhang, C.; Li, Y. J.; Luo, M.; Ren, H. W. et al. Accessing neuroinflammation sites: Monocyte/neutrophil-mediated drug delivery for cerebral ischemia. Sci. Adv. 2019, 5, eaau8301.

Lu, L.; Zhao, X. J.; Fu, T. W.; Li, K.; He, Y.; Luo, Z.; Dai, L. L.; Zeng, R.; Cai, K. Y. An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy. Biomaterials 2020, 230, 119666.

Lu, Y. F.; Li, C.; Chen, Q. J.; Liu, P. X.; Guo, Q.; Zhang, Y.; Chen, X. L.; Zhang, Y. J.; Zhou, W. X.; Liang, D. H. et al. Microthrombus-targeting micelles for neurovascular remodeling and enhanced microcirculatory perfusion in acute ischemic stroke. Adv. Mater. 2019, 31, 1808361.

Israel, L. L.; Braubach, O.; Galstyan, A.; Chiechi, A.; Shatalova, E. S.; Grodzinski, Z.; Ding, H.; Black, K. L.; Ljubimova, J. Y.; Holler, E. A combination of tri-leucine and angiopep-2 drives a polyanionic polymalic acid nanodrug platform across the blood-brain barrier. ACS Nano 2019, 13, 1253–1271.

Lee, Y.; Lee, J.; Kim, M.; Kim, G. Y.; Choi, J. S.; Lee, M. Brain gene delivery using histidine and arginine-modified dendrimers for ischemic stroke therapy. J. Control. Release 2021, 330, 907–919.

Lugasi, L.; Grinberg, I.; Rudnick-Glick, S.; Okun, E.; Einat, H.; Margel, S. Designed proteinoid polymers and nanoparticles encapsulating risperidone for enhanced antipsychotic activity. J. Nanobiotechnol. 2020, 18, 149.

Mukherjee, A.; Waters, A. K.; Kalyan, P.; Achrol, A. S.; Kesari, S.; Yenugonda, V. M. Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: State of the art, emerging technologies, and perspectives. Int. J. Nanomedicine 2019, 14, 1937–1952.

Tang, F. Q.; Li, L. L.; Chen, D. Mesoporous silica nanoparticles: Synthesis, biocompatibility and drug delivery. Adv. Mater. 2012, 24, 1504–1534.

Spinelli, A.; Girelli, M.; Arosio, D.; Polito, L.; Podini, P.; Martino, G.; Seneci, P.; Muzio, L.; Menegon, A. Intracisternal delivery of PEG-coated gold nanoparticles results in high brain penetrance and long-lasting stability. J. Nanobiotechnol. 2019, 17, 49.

Vangijzegem, T.; Stanicki, D.; Laurent, S. Magnetic iron oxide nanoparticles for drug delivery: Applications and characteristics. Expert Opin. Drug Deliv. 2019, 16, 69–78.

Chen, D. Q.; Dougherty, C. A.; Zhu, K. C.; Hong, H. Theranostic applications of carbon nanomaterials in cancer: Focus on imaging and cargo delivery. J. Control. Release 2015, 210, 230–245.

Anfray, C.; Komaty, S.; Corroyer-Dulmont, A.; Zaarour, M.; Helaine, C.; Ozcelik, H.; Allioux, C.; Toutain, J.; Goldyn, K.; Petit, E. et al. Nanosized zeolites as a gas delivery platform in a glioblastoma model. Biomaterials 2020, 257, 120249.

Wu, V. M.; Huynh, E.; Tang, S.; Uskoković, V. Brain and bone cancer targeting by a ferrofluid composed of superparamagnetic iron-oxide/silica/carbon nanoparticles (earthicles). Acta Biomater. 2019, 88, 422–447.

Hashemi, P.; Luckau, L.; Mischnick, P.; Schmidt, S.; Stosch, R.; Wünsch, B. Biomacromolecules as tools and objects in nanometrology-current challenges and perspectives. Anal. Bioanal. Chem. 2017, 409, 5901–5909.

Yang, Z. Z.; Du, Y. T.; Sun, Q.; Peng, Y. W.; Wang, R. D.; Zhou, Y.; Wang, Y. Q.; Zhang, C. L.; Qi, X. R. Albumin-based nanotheranostic probe with hypoxia alleviating potentiates synchronous multimodal imaging and phototherapy for glioma. ACS Nano 2020, 14, 6191–6212.

Fang, R. H.; Kroll, A. V.; Gao, W. W.; Zhang, L. F. Cell membrane coating nanotechnology. Adv. Mater. 2018, 30, 1706759.

Zhuang, J.; Gong, H.; Zhou, J. R.; Zhang, Q. Z.; Gao, W. W.; Fang, R. H.; Zhang, L. F. Targeted gene silencing in vivo by platelet membrane-coated metal-organic framework nanoparticles. Sci. Adv. 2020, 6, eaaz6108.

Chen, H. Y.; Deng, J.; Wang, Y.; Wu, C. Q.; Li, X.; Dai, H. W. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy. Acta Biomater. 2020, 112, 1–13.

He, W. X.; Mei, Q. Y.; Li, J.; Zhai, Y. T.; Chen, Y. T.; Wang, R.; Lu, E. H.; Zhang, X. Y.; Zhang, Z. W.; Sha, X. Y. Preferential targeting cerebral ischemic lesions with cancer cell-inspired nanovehicle for ischemic stroke treatment. Nano Lett. 2021, 21, 3033–3043.

Zheng, T.; Wang, W. T.; Ashley, J.; Zhang, M.; Feng, X. T.; Shen, J.; Sun, Y. Self-assembly protein superstructures as a powerful chemodynamic therapy nanoagent for glioblastoma treatment. Nano-Micro Lett. 2020, 12, 151.

Cully, M. Exosome-based candidates move into the clinic. Nat. Rev. Drug Discov. 2021, 20, 6–7.